Breast cancer survivor describes how Symphony helped her avoid chemotherapy to the House Medical Technology Caucus on Capital Hill
December 2012 AdvaMed Dx
Agendia Appoints Dr. Neil M. Barth MD, FACP, as Chief Medical Officer
IRVINE, CA, and AMSTERDAM, THE NETHERLANDS, January 25, 2013 – Read More
Study Indicates Breast Cancer Diagnosis Is More Accurate with New Genomic Tests
SAN ANTONIO – The latest generation of genomic tests for breast Read More
Agendia Announces Five Studies in Breast Cancer for Presentation at the American Society of Clinical Oncology 2012 Breast Cancer Symposium
AMSTERDAM, THE NETHERLANDS, and IRVINE, CA, September 13, 2012 – Agendia, an Read More
Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 29, 2012 – Read More
Agendia Earns ISO Certification for Facilities in Amsterdam and Irvine
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 20, 2012 – Read More
Agendia Appoints Dr. Stefan Glück to Chair Medical Advisory Board
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, August 9, 2012 – Read More
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, July 10, 2012 – Read More
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, July 9, 2012 – Read More
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Agendia’s Microarray-based Gene Expression Profile Provides Critical Additional Information for Read More
